CMIC Group is the largest clinical CRO in Japan with a global footprint; providing end-to-end solutions for the entire drug development value chain. Our unique Pharmaceutical Value Creator model provides comprehensive services for contract development and manufacturing, contract sales, healthcare services and an innovative pharma model to bring highly desired treatments to the Japanese market. We help pharmaceutical, biotech and medical device companies to enter the Japan market, to conduct clinical trials in Asia, or to bridge your drug development and manufacturing needs between the US and Japan.


CMIC Inquiries
Peyni Chan Director, International Business Development
Hamamatsu-cho Bldg. 1-1-1 Shibaura, Minato-ku, Tokyo 105-0023